Psychedelics, Psychiatry, and Moving Toward the Monstrous
My personal psychiatric guru, Nazi survivor Dorothea Buck, described one of psychiatry’s great failures as its utter lack of dialogue with patients about what they experience.
“By being declared ill in a medicinal sense,” Buck wrote, the diagnosed “are deprived of the human significance of [our] thoughts and feelings.”
Buck was not a psychiatrist but a patient, diagnosed, as I once was, with schizophrenia. I share her wonder at the assumption that what someone depressed, or hearing voices is experiencing—to give two examples--doesn’t in and of itself matter. I hear voices, which can be frightening or enlightening. I’ve had depressive periods that came from nowhere and others that signaled a need for change in my life. According to our diagnostic criteria, any non-consensus experience just counts as a "symptom" and indicates the need for drugs.
Therapeutic Psychedelics
What could bring the value of all consciousness back to psychiatry? I’ve wondered about this question for a long time. I would never have guessed one answer that’s emerged over the past few years: therapeutic psychedelics.
A great discussion of this movement lies in Michael Pollan’s book How to Change Your Mind, which explores the use of mind-altering drugs to address problems like trauma, facing death, and depression. Pollan himself tries drugs like psilocybin, finding under its influence a world “jeweled with light.”
Patients and Pollan use substances like psilocybin with trained guides and explore their © Psychology Today
